Characteristics | Hazard ratio (95% CI) |
---|---|
Baseline age in years | 0.980 (0.966, 0.9941) |
Sex | |
Female | 1.0 |
Male | 0.747 (0.577, 0.968) |
Baseline functional status | |
Working | 1.0 |
Ambulatory | 1.005 (0.742, 1.362) |
Bedridden | 0.910 (0.441, 1.879) |
Baseline WHO clinical stage | |
Stage I | 1.0 |
Stage II | 1.128 (0.593, 2.146) |
Stage III | 1.567 (0.887, 2.769) |
Stage IV | 1.514 (0.776, 2.952) |
First treatment class | |
AZT-3TC | 1.0 |
D4t-3TC | 1.223 (0.950, 1.575) |
D4t (30) | 1.243 (0.672, 2.298) |
Baseline CD4 count | 1.006 (1.005, 1.008) |
P | 1.186 (1.082, 1.299) |
Theta | 0.052 (0.005, 0.551) |